News & Perspective

Sep 15, 2009

Sep 15, 2009

FDA approves four companies' H1N1 vaccines

(CIDRAP News) – The Food and Drug Administration (FDA) today announced approval of four of the five different versions of the pandemic H1N1 vaccine ordered by the US government, helping to pave the way for a vaccination campaign expected to start in October.

Sep 10, 2009

Sep 10, 2009

Experts push hard for early seasonal flu vaccination

(CIDRAP News) – Today was the 12th year the National Foundation for Infectious Diseases (NFID) has held a press conference to discuss its expectations for the upcoming flu season, but discussions were far from routine, reflecting uncertainty surrounding the pandemic flu strain and the complexity of launching two vaccine campaigns.

Sep 10, 2009

Early results suggest 1 dose of H1N1 vaccine may be protective

(CIDRAP News) – Preliminary clinical trial results suggest that pandemic H1N1 vaccines made by Novartis and CSL Ltd. will provide protection in adults with just one dose, raising hope for a less difficult immunization program than has been anticipated.

Aug 24, 2009

Aug 24, 2009

Panel urges HHS to prepare for H1N1 vaccine safety concerns

(CIDRAP News) – An advisory committee today called on the Department of Health and Human Services (HHS) to be ready to respond quickly to safety concerns that may emerge during this fall's novel H1N1 influenza vaccination campaign.

Aug 21, 2009

Aug 21, 2009

First H1N1 vaccine trial data expected in mid-September

(CIDRAP News) – Federal health officials today said the first results of novel H1N1 vaccine trials—needed for determining the number and size of doses people will get—are expected in mid-September.

Two trials in adult and elderly volunteers started Aug 7 and are now almost fully enrolled, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), at a press teleconference.

Aug 18, 2009

Aug 18, 2009

FDA clears CSL's vaccine-finishing facility in US

(CIDRAP News) – The US Food and Drug Administration (FDA) today approved a vaccine filling and packaging facility in Illinois owned by CSL Biotherapies, one of the five companies under contract to make novel H1N1 vaccines for the United States, the company announced.

Aug 14, 2009

Aug 14, 2009

Officials lower expectations for size of first novel flu vaccine deliveries

(CIDRAP News) – Federal officials today during a pandemic H1N1 planning update dialed back the number of novel flu vaccine doses they expect in October from 120 million to 45 million, listing several reasons for the smaller projection.

Jul 31, 2009

Jul 31, 2009

CDC to seek public's advice on H1N1 vaccination drive

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) plans to gather the public's thoughts in August on how big this fall's H1N1 influenza vaccination drive should be.

Jul 30, 2009

Jul 30, 2009

Packaging, not yield, may be problem for nasal-spray H1N1 vaccine

(CIDRAP News) – While most vaccine manufacturers have reaped below-average crops of H1N1 influenza vaccine virus from the eggs in which they're grown, MedImmune Inc. has a different problem: high virus yields, but a potential shortage of the devices used to spray the vaccine into the nose.

Jul 29, 2009

Jul 29, 2009

ACIP targets up to 159 million Americans for H1N1 vaccination

(CIDRAP News) – The top US advisory panel on immunizations recommended today that groups totaling up to 159 million people be targeted for vaccination against the pandemic H1N1 influenza virus but that a narrower population of about 41 million have priority if initial supplies are short.

Pages

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»